Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial ResultsPRNewsWire • 07/24/25
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been CompromisedGlobeNewsWire • 07/14/25
Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common StockPRNewsWire • 05/28/25
Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common StockPRNewsWire • 05/14/25
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual MeetingPRNewsWire • 05/05/25
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial ResultsPRNewsWire • 04/21/25
Strength Seen in Artivion (AORT): Can Its 7.9% Jump Turn into More Strength?Zacks Investment Research • 04/10/25
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferencePRNewsWire • 03/04/25
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a TurnaroundZacks Investment Research • 02/27/25
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial ResultsPRNewsWire • 02/10/25
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual MeetingPRNewsWire • 01/27/25
US medical device giant Artivion says hackers stole files during cybersecurity incidentTechCrunch • 12/09/24
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid ProsthesisPRNewsWire • 12/09/24
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial ResultsPRNewsWire • 10/24/24